Apolipoprotein A-I-stimulated Apolipoprotein E Secretion from Human Macrophages Is Independent of Cholesterol Efflux

Autor: Carmel M. Quinn, Gerd Assmann, Mayakonda N. Palgunachari, Dimitri Sviridov, Janelle Wright, John R. Burnett, Gattadahalli M. Anantharamaiah, Kerry-Anne Rye, Ying Fu, Maaike Kockx, Sissel Lund Katz, Katharina Gaus, Michael C. Phillips, Leonard Kritharides, Roger T. Dean, Stephan Rust, Timothy Sloane, David R. Sullivan, Wendy Jessup
Rok vydání: 2004
Předmět:
Apolipoprotein E
Sucrose
Time Factors
Apolipoprotein B
Biochemistry
Monocytes
chemistry.chemical_compound
Tangier disease
polycyclic compounds
RNA Processing
Post-Transcriptional

Phospholipids
Tangier Disease
Reverse Transcriptase Polymerase Chain Reaction
Exons
Recombinant Proteins
Cholesterol
Electrophoresis
Polyacrylamide Gel

lipids (amino acids
peptides
and proteins)

Efflux
Lipoproteins
HDL

ATP Binding Cassette Transporter 1
medicine.medical_specialty
Blotting
Western

Enzyme-Linked Immunosorbent Assay
Biology
Apolipoproteins E
Internal medicine
Centrifugation
Density Gradient

medicine
Humans
Biotinylation
Secretion
Autocrine signalling
Molecular Biology
Apolipoprotein A-I
Macrophages
nutritional and metabolic diseases
Cell Biology
Lipid Metabolism
medicine.disease
Protein Structure
Tertiary

Endocrinology
chemistry
ABCA1
Mutation
Leukocytes
Mononuclear

biology.protein
ATP-Binding Cassette Transporters
Peptides
Ultracentrifugation
Zdroj: Journal of Biological Chemistry. 279:25966-25977
ISSN: 0021-9258
Popis: Apolipoprotein A-I (apoA-I)-mediated cholesterol efflux involves the binding of apoA-I to the plasma membrane via its C terminus and requires cellular ATP-binding cassette transporter (ABCA1) activity. ApoA-I also stimulates secretion of apolipoprotein E (apoE) from macrophage foam cells, although the mechanism of this process is not understood. In this study, we demonstrate that apoA-I stimulates secretion of apoE independently of both ABCA1-mediated cholesterol efflux and of lipid binding by its C terminus. Pulse-chase experiments using (35)S-labeled cellular apoE demonstrate that macrophage apoE exists in both relatively mobile (E(m)) and stable (E(s)) pools, that apoA-I diverts apoE from degradation to secretion, and that only a small proportion of apoA-I-mobilized apoE is derived from the cell surface. The structural requirements for induction of apoE secretion and cholesterol efflux are clearly dissociated, as C-terminal deletions in recombinant apoA-I reduce cholesterol efflux but increase apoE secretion, and deletion of central helices 5 and 6 decreases apoE secretion without perturbing cholesterol efflux. Moreover, a range of 11- and 22-mer alpha-helical peptides representing amphipathic alpha-helical segments of apoA-I stimulate apoE secretion whereas only the C-terminal alpha-helix (domains 220-241) stimulates cholesterol efflux. Other alpha-helix-containing apolipoproteins (apoA-II, apoA-IV, apoE2, apoE3, apoE4) also stimulate apoE secretion, implying a positive feedback autocrine loop for apoE secretion, although apoE4 is less effective. Finally, apoA-I stimulates apoE secretion normally from macrophages of two unrelated subjects with genetically confirmed Tangier Disease (mutations C733R and c.5220-5222delTCT; and mutations A1046D and c.4629-4630insA), despite severely inhibited cholesterol efflux. We conclude that apoA-I stimulates secretion of apoE independently of cholesterol efflux, and that this represents a novel, ABCA-1-independent, positive feedback pathway for stimulation of potentially anti-atherogenic apoE secretion by alpha-helix-containing molecules including apoA-I and apoE.
Databáze: OpenAIRE